Literature DB >> 5271165

Globoid cell leucodystrophy (Krabbe's disease): deficiency of galactocerebroside beta-galactosidase.

K Suzuki, Y Suzuki.   

Abstract

Profound deficiency of a specific enzyme, galactocerebroside beta-galactosidase, has been demonstrated in the brains, liver, and spleen of three patients with Krabbe's globoid cell leucodystrophy. The activity of this enzyme was normal in a variety of other cerebral diseases, including those with similarly devasted white matter. The lack of enzyme activity was not due to an inhibitor in the tissue, nor is it due to a shift in the pH optimum. The deficiency of galactocerebroside beta-galactosidase as the primary enzymatic defect can account for the morphological and biochemical characteristics of this disease better than the previously reported deficiency of cerebroside-sulfatide sulfotransferase.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5271165      PMCID: PMC283044          DOI: 10.1073/pnas.66.2.302

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  Purification of cerebroside galactosidase from rat brain.

Authors:  D M Bowen; N S Radin
Journal:  Biochim Biophys Acta       Date:  1968-05-01

2.  Properties of cerebroside galactosidase.

Authors:  D M Bowen; N S Radin
Journal:  Biochim Biophys Acta       Date:  1968-05-01

3.  Cerebroside galactosidase: a method for determination and a comparison with other lysosomal enzymes in developing rat brain.

Authors:  D M Bowen; N S Radin
Journal:  J Neurochem       Date:  1969-04       Impact factor: 5.372

4.  Spongy degeneration of the brain. A chemical study of two cases including isolation and characterization of myelin.

Authors:  S Kamoshita; I Rapin; K Suzuki; K Suzuki
Journal:  Neurology       Date:  1968-10       Impact factor: 9.910

5.  Lactosylceramide galactosidase: comparison with other sphingolipid hydrolases in developing rat brain.

Authors:  N S Radin; L Hof; R M Bradley; R O Brady
Journal:  Brain Res       Date:  1969-07       Impact factor: 3.252

6.  Isolation of beta-galactosidase and beta-glucosidase from brain.

Authors:  S Gatt; M M Rapport
Journal:  Biochim Biophys Acta       Date:  1966-03-07

7.  Isolation of beta-N-acetylhexosaminidase, beta-N-acetylglucosaminidase, and beta-N-acetylgalactosaminidase from calf brain.

Authors:  Y Z Frohwein; S Gatt
Journal:  Biochemistry       Date:  1967-09       Impact factor: 3.162

8.  Tay-Sachs disease: generalized absence of a beta-D-N-acetylhexosaminidase component.

Authors:  S Okada; J S O'Brien
Journal:  Science       Date:  1969-08-15       Impact factor: 47.728

9.  Generalized gangliosidosis: beta-galactosidase deficiency.

Authors:  S Okada; J S O'Brien
Journal:  Science       Date:  1968-05-31       Impact factor: 47.728

10.  Cerebroside galactosidase of brain.

Authors:  A K Hajra; D M Bowen; Y Kishimoto; N S Radin
Journal:  J Lipid Res       Date:  1966-05       Impact factor: 5.922

View more
  121 in total

Review 1.  Biochemistry and genetics of gangliosidoses.

Authors:  K Sandhoff; H Christomanou
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

Review 2.  Basic findings and current developments in sphingolipidoses.

Authors:  H Pilz; R Heipertz; D Seidel
Journal:  Hum Genet       Date:  1979-03-12       Impact factor: 4.132

3.  Mesenchymal lineage stem cells have pronounced anti-inflammatory effects in the twitcher mouse model of Krabbe's disease.

Authors:  Cynthia B Ripoll; Mette Flaat; Jessica Klopf-Eiermann; Jeanne M Fisher-Perkins; Cynthia B Trygg; Brittni A Scruggs; Marjorie L McCants; Helen Paige Leonard; Amy F Lin; Shijia Zhang; Michelle E Eagle; Xavier Alvarez; Yu Teh Li; Su Chen Li; Jeffrey M Gimble; Bruce A Bunnell
Journal:  Stem Cells       Date:  2011-01       Impact factor: 6.277

4.  Seitelberger's connatal form of Pelizaeus-Merzbacher Disease. Case report, clinical, pathological and biochemical findings.

Authors:  J Ulrich; N Herschkowitz
Journal:  Acta Neuropathol       Date:  1977-10-10       Impact factor: 17.088

Review 5.  Treatment for Krabbe's disease: Finding the combination.

Authors:  Christina R Mikulka; Mark S Sands
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

6.  Quantitative structural multiclass lipidomics using differential mobility: electron impact excitation of ions from organics (EIEIO) mass spectrometry.

Authors:  Takashi Baba; J Larry Campbell; J C Yves Le Blanc; Paul R S Baker; Kazutaka Ikeda
Journal:  J Lipid Res       Date:  2018-03-14       Impact factor: 5.922

Review 7.  Properties, metabolism and roles of sulfogalactosylglycerolipid in male reproduction.

Authors:  Nongnuj Tanphaichitr; Kessiri Kongmanas; Kym F Faull; Julian Whitelegge; Federica Compostella; Naoko Goto-Inoue; James-Jules Linton; Brendon Doyle; Richard Oko; Hongbin Xu; Luigi Panza; Arpornrad Saewu
Journal:  Prog Lipid Res       Date:  2018-08-25       Impact factor: 16.195

8.  Diffusion tensor imaging of the mouse brainstem and cervical spinal cord.

Authors:  Joong Hee Kim; Sheng-Kwei Song
Journal:  Nat Protoc       Date:  2013-02       Impact factor: 13.491

9.  The interrelations between high- and low-molecular weight forms of normal and mutant (Krabbe-disease) galactocerebrosidase.

Authors:  Y Ben-Yoseph; M Hungerford; H L Nadler
Journal:  Biochem J       Date:  1980-07-01       Impact factor: 3.857

10.  Krabbe's globoid cell leucodystrophy. Studies on galactosylceramide beta-galactosidase and non-specific beta-galactosidase of leucocytes, cultured skin fibroblasts, and amniotic fluid cells.

Authors:  G T Besley; A D Bain
Journal:  J Med Genet       Date:  1976-06       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.